Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Arcus Biosciences

Arcus Biosciences
2015 FOUNDED
PUBLIC STATUS
101-200 EMPLOYEES
RCUS STOCK SYMBOL
$9.52 SHARE PRICE (As of Wednesday Closing)
Description

Arcus Biosciences Inc is a clinical-stage biopharmaceutical company which focuses on creating innovative cancer immunotherapies by leveraging underexploited biological opportunities. The company focuses on an ATP-adenosine pathway which is a key driver of immunosuppression in the tumor microenvironment to create and optimize differentiated small-molecule immuno-oncology product candidates. The pipeline products of the company include dual and selective A2R antagonists, small-molecule and antibody programs which target solid tumors. The company operates through the single segment being the business of developing and commercializing immunotherapies.

Ownership Status
Publicly Held
Financing Status
Formerly VC-backed
Primary Industry
Biotechnology
Other Industries
Drug Discovery
Stock Exchange
NYS
Primary Office
  • 3928 Point Eden Way
  • Hayward, CA 94545
  • United States

+1 (510) 000-0000
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore Arcus Biosciences’s full profile, request a free trial.

Arcus Biosciences Stock Performance

52 wk Range Market Cap Prev. Close EPS Average Volume Shares
$8.57 - $17.50 $424M $9.69 -$1.25 99K 44.5M

Arcus Biosciences Financials Summary

In Thousands,
USD
TTM
31-Mar-2019
FY 2018
31-Dec-2018
FY 2017
31-Dec-2017
FY 2016
31-Dec-2016
Enterprise Value 299,693 303,064
Revenue 8,853 8,353 1,413 0
EBITDA (56,600) (50,852) (51,245) (16,868)
Net Income (54,310) (49,594) (53,082) (17,970)
Total Assets 258,530 274,925 190,486 109,702
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Arcus Biosciences Valuation and Funding

Deal Type Date Amount Post-Val Valuation/
EBITDA
Debt Status

This information is reserved for PitchBook Platform users. To explore Arcus Biosciences‘s full profile, request access.

Request full access to PitchBook

Arcus Biosciences Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion
Price
% Owned

This information is reserved for PitchBook Platform users. To explore Arcus Biosciences‘s full profile, request access.

Request full access to PitchBook
To view this company’s complete Cap Table, request access »

Arcus Biosciences Competitors (9)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Jounce Therapeutics Failed Transaction (M&A) Cambridge, MA 000 00000 000000&0
00000 Formerly PE-Backed Paris, France 00 00000 00000000000 00000
00000000 Formerly VC-backed Munich, Germany 000.00 000000&0 000.00
0000000 0000000000 Formerly VC-backed Heidelberg, Germany 000 00000 00000000000 00000
00000 Venture Capital-Backed Thousand Oaks, CA 00000 00.000 000000000000 00.000
To view this company’s complete list of competitors, request access »

Arcus Biosciences Investors

Investor Name Investor Type Holding Participating Rounds Investor Since Board Seat Contact Info

This information is reserved for PitchBook Platform users. To explore Arcus Biosciences‘s full profile, request access.

Request full access to PitchBook

Arcus Biosciences Executive Team (13)

Name Title Board
Seat
Contact
Info
Jennifer Jarrett Chief Operating Officer & Chief Financial Officer
Jay Powers Ph.D Senior Vice President, Drug Discovery
Steven Chan Vice President, Finance & Corporate Controller
Yvonne Gehring Vice President, Human Resources & Operations
Ulrike Schindler Vice President of Biology

1 Former Executive

You’re viewing 5 of 13 executives. Get the full list »

Arcus Biosciences Board Members (6)

Name Representing Role Since Contact
Info
David Beier JD Self Board Member 000 0000
Juan Jaen Ph.D Self Co-Founder, President & Board Member 000 0000
Kathryn Falberg Self Board Member 000 0000
Peter Svennilson The Column Group Board Member 000 0000
Terry Rosen Ph.D Self Co-Founder, Chief Executive Officer & Board Member 000 0000
You’re viewing 5 of 6 board members. Get the full list »